Back
Vistagen Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
VTGN
Vistagen Therapeutics, Inc.
Last Price:
$0.72
Seasonality Move:
20.93%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTGN is experiencing slight buying pressure.
Vistagen Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.66 | Sell |
| 20-day SMA: | 3.23 | Sell |
| 50-day SMA: | 3.79 | Sell |
| 200-day SMA: | 2.99 | Sell |
| 8-day EMA: | 0.58 | Buy |
| 20-day EMA: | 0.34 | Buy |
| 50-day EMA: | 0.16 | Buy |
| 200-day EMA: | 0.04 | Buy |
Vistagen Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 22.97 | Sell |
| Chaikin Money Flow: | 442815 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.94 - 5.08) | Sell |
| Bollinger Bands (100): | (2.7 - 4.46) | Sell |
Vistagen Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vistagen Therapeutics, Inc. Stock
Is Vistagen Therapeutics, Inc. Stock a Buy?
-
Vistagen Therapeutics, Inc. share price is 0.73 while VTGN 8-day simple moving average is 1.66, which is a Sell signal.
-
The stock price of VTGN is 0.73 while Vistagen Therapeutics, Inc. 20-day SMA is 3.23, which makes it a Sell.
-
Vistagen Therapeutics, Inc. 50-day simple moving average is 3.79 while VTGN share price is 0.73, making it a Sell technically.
-
VTGN stock price is 0.73 and Vistagen Therapeutics, Inc. 200-day simple moving average is 2.99, creating a Sell signal.
VTGN Technical Analysis vs Fundamental Analysis
Sell
23
Vistagen Therapeutics, Inc. (VTGN)
is a Sell
Is Vistagen Therapeutics, Inc. a Buy or a Sell?
-
Vistagen Therapeutics, Inc. stock is rated a SellThe current Vistagen Therapeutics, Inc. [VTGN] share price is $0.73. The Score for VTGN is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Vistagen Therapeutics, Inc. Stock Info
Market Cap:
28.7M
Price in USD:
0.73
Share Volume:
1.8M
Vistagen Therapeutics, Inc. 52-Week Range
52-Week High:
5.14
52-Week Low:
0.68
Sell
23
Vistagen Therapeutics, Inc. (VTGN)
is a Sell
Vistagen Therapeutics, Inc. Share Price Forecast
-
What is the Vistagen Therapeutics, Inc. stock price today?The Vistagen Therapeutics, Inc. stock price is 0.73 USD today.
-
Will VTGN stock go up or go down?Vistagen Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Vistagen Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vistagen Therapeutics, Inc. is overvalued.
Is Vistagen Therapeutics, Inc. Stock a Buy?
-
Vistagen Therapeutics, Inc. share price is 0.73 while VTGN 8-day exponential moving average is 0.58, which is a Buy signal.
-
The stock price of VTGN is 0.73 while Vistagen Therapeutics, Inc. 20-day EMA is 0.34, which makes it a Buy.
-
Vistagen Therapeutics, Inc. 50-day exponential moving average is 0.16 while VTGN share price is 0.73, making it a Buy technically.
-
VTGN stock price is 0.73 and Vistagen Therapeutics, Inc. 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of Vistagen Therapeutics, Inc.
Is Vistagen Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Vistagen Therapeutics, Inc.
Should I short Vistagen Therapeutics, Inc. stock?
-
VTGN Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Vistagen Therapeutics, Inc. is a Buy
-
Vistagen Therapeutics, Inc. Relative Strength Index (RSI) is 22.97, which suggest Vistagen Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Vistagen Therapeutics, Inc. is (1.94 - 5.08), which suggest Vistagen Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Vistagen Therapeutics, Inc. is (2.7 - 4.46), which suggest Vistagen Therapeutics, Inc. is a Sell
* Vistagen Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.